About 600 reports

Global Genetic Disorders Partnering 2015 to 2022 provides the full collection of Genetic Disorders disease deals signed between the world’s pharmaceutical and biotechnology companies since 2015. Trends in Genetic Disorders partnering deals Financial deal terms for headline, upfront and royalty by stage of development Genetic...

  • Genetic Disorder
  • World

Primary Immune Deficiency (PID) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary This latest Pharmaceutical and Healthcare disease pipeline guide Primary Immune Deficiency (PID) - Drugs in Development by Stages, Target, MoA, RoA, Molecule Type...

  • Genetic Disorder
  • Infectious Disease
  • World
  • South Africa
  • Pharmaceutical Exports
  • Pharmaceutical Production

Primary Immune Deficiency (PID) (Genitourinary Disorders) - Drugs In Development, 2021 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Primary Immune Deficiency (PID) (Genitourinary Disorders) - Drugs In Development, 2021, provides an overview of the Primary Immune Deficiency...

  • Genetic Disorder
  • Drug Development
  • Infectious Disease
  • World
  • South Africa
  • Pharmaceutical Registrations
  • Medical Technology Density

Achromatopsia (Genetic Disorders) - Drugs in Development, 2021 Summary Achromatopsia (Genetic Disorders) - Drugs in Development, 2021 provides an overview of the Achromatopsia pipeline landscape. The report provides comprehensive information on the therapeutics under development for Achromatopsia,...

  • Genetic Disorder
  • Eye Disease
  • World

Cystinuria (Genetic Disorders) - Drugs in Development, 2021 Summary Cystinuria (Genetic Disorders) - Drugs in Development, 2021 provides an overview of the Cystinuria pipeline landscape. The report provides comprehensive information on the therapeutics under development for Cystinuria, complete...

  • Genetic Disorder
  • World

Global Predictive Presymptomatic Testing Market 2022-2026 The analyst has been monitoring the predictive presymptomatic testing market and it is poised to grow by $ 2.45 bn during 2022-2026 progressing at a CAGR of 9.6% during the forecast period. Our report on the predictive presymptomatic testing market provides a holistic...

  • Genetic Disorder
  • Healthcare
  • Laboratory
  • Marketing Research
  • Genetic Testing
  • World
  • Health Expenditure

The South and Central America animal genetics market is expected to reach US$ 488.51 million in 2027 from US$ 334.10 million in 2019. The market is estimated to grow with a CAGR of 5.0% from 2020 to 2027. The growth of this market is attributed to the factors such as the high rise in the animal population, growing consumption of animal...

  • Genetic Disorder
  • Central America
  • Pork Production
  • Livestock Production

The North America animal genetics market is expected to reach US$ 3,428.06 million in 2027 from US$ 2,082.34 million in 2019. The market is estimated to grow with a CAGR of 6.5% from 2020 to 2027. The growth of this market is attributed to the factors such as the increasing livestock population, growing adoption of animal derived protein...

  • Genetic Disorder
  • Cattle
  • North America
  • Livestock Production
  • Pork Production

The Middle East and Africa animal genetics market is expected to reach US$ 302.04 million in 2027 from US$ 219.55 million in 2019. The market is estimated to grow with a CAGR of 4.2% from 2020 to 2027. The growth of this market is attributed to the factors such as the growing adoption of progressive genetic practices like embryo transfer...

  • Cattle
  • Genetic Disorder
  • Africa
  • Middle East
  • Pork Production
  • Poultry Meat Consumption

The Asia Pacific animal genetics market is expected to reach US$ 1,683.59 million in 2027 from US$ 994.44 million in 2019. The market is estimated to grow with a CAGR of 6.9% from 2020 to 2027. The growth of this market is attributed to the factors such as a rise in animal production, increased consumption of animal meat, and a significant...

  • Cattle
  • Genetic Disorder
  • APAC
  • Livestock Production
  • Pork Production

Turner Syndrome (Genetic Disorders) - Drugs in Development, 2021 Summary Turner Syndrome (Genetic Disorders) - Drugs in Development, 2021 provides an overview of the Turner Syndrome pipeline landscape. The report provides comprehensive information on the therapeutics under development for...

  • Genetic Disorder
  • World

Barth Syndrome (Genetic Disorders) - Drugs in Development, 2021 Summary Barth Syndrome (Genetic Disorders) - Drugs in Development, 2021 provides an overview of the Barth Syndrome pipeline landscape. The report provides comprehensive information on the therapeutics under development for Barth...

  • Genetic Disorder
  • Neurological Disorder
  • World

Congenital Ichthyosis (Genetic Disorders) - Drugs in Development, 2021 Summary Congenital Ichthyosis (Genetic Disorders) - Drugs in Development, 2021 provides an overview of the Congenital Ichthyosis pipeline landscape. The report provides comprehensive information on the therapeutics under...

  • Genetic Disorder
  • Dermatological Condition
  • World

Alport Syndrome (Genetic Disorders) - Drugs in Development, 2021 Summary Alport Syndrome (Genetic Disorders) - Drugs in Development, 2021 provides an overview of the Alport Syndrome pipeline landscape. The report provides comprehensive information on the therapeutics under development for...

  • Genetic Disorder
  • World

Ichthyosis Vulgaris (Genetic Disorders) - Drugs in Development, 2021 Summary Ichthyosis Vulgaris (Genetic Disorders) - Drugs in Development, 2021 provides an overview of the Ichthyosis Vulgaris pipeline landscape. The report provides comprehensive information on the therapeutics under development...

  • Genetic Disorder
  • Dermatological Condition
  • World

Tuberous Sclerosis (Genetic Disorders) - Drugs in Development, 2021 Summary Tuberous Sclerosis (Genetic Disorders) - Drugs in Development, 2021 provides an overview of the Tuberous Sclerosis pipeline landscape. The report provides comprehensive information on the therapeutics under development...

  • Genetic Disorder
  • Neurological Disorder
  • World

Angelman Syndrome (Genetic Disorders) - Drugs in Development, 2021 Summary Angelman Syndrome (Genetic Disorders) - Drugs in Development, 2021 provides an overview of the Angelman Syndrome pipeline landscape. The report provides comprehensive information on the therapeutics under development...

  • Genetic Disorder
  • Neurological Disorder
  • World

The Europe animal genetics market is expected to reach US$ 1,803.02 million in 2027 from US$ 1,148.25 million in 2019. The market is estimated to grow with a CAGR of 5.9% from 2020 to 2027. The growth of this market is attributed to the factors such as the rising number of livestock population across Europe and an increasing diversity...

  • Cattle
  • Genetic Disorder
  • Europe
  • Livestock Production
  • Pork Production

Primary Immune Deficiency (PID) - Pipeline Review, H2 2020 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Primary Immune Deficiency (PID) - Pipeline Review, H2 2020, provides an overview of the Primary Immune Deficiency (PID) (Genetic Disorders) pipeline landscape. Primary...

  • Infectious Disease
  • Genetic Disorder
  • World
  • Medical Technology Density
  • Paid Claims

Chronic Granulomatous Disease (Genetic Disorders) - Drugs in Development, 2021 Summary Chronic Granulomatous Disease (Genetic Disorders) - Drugs in Development, 2021 provides an overview of the Chronic Granulomatous Disease pipeline landscape. The report provides comprehensive information...

  • Genetic Disorder
  • World

Hutchinson-Gilford Progeria (Genetic Disorders) - Drugs in Development, 2021 Summary Hutchinson-Gilford Progeria (Genetic Disorders) - Drugs in Development, 2021 provides an overview of the Hutchinson-Gilford Progeria pipeline landscape. The report provides comprehensive information on the...

  • Genetic Disorder
  • World

Urea Cycle Disorders (Genetic Disorders) - Drugs in Development, 2021 Summary Urea Cycle Disorders (Genetic Disorders) - Drugs in Development, 2021 provides an overview of the Urea Cycle Disorders pipeline landscape. The report provides comprehensive information on the therapeutics under development...

  • Genetic Disorder
  • World

Inherited Mitochondrial Disorders (Genetic Disorders) - Drugs in Development, 2021 Summary Inherited Mitochondrial Disorders (Genetic Disorders) - Drugs in Development, 2021 provides an overview of the Inherited Mitochondrial Disorders pipeline landscape. The report provides comprehensive...

  • Genetic Disorder
  • World

X-Linked SCID (Genetic Disorders) - Drugs in Development, 2021 Summary X-Linked SCID (Genetic Disorders) - Drugs in Development, 2021 provides an overview of the X-Linked SCID pipeline landscape. The report provides comprehensive information on the therapeutics under development for X-Linked...

  • Genetic Disorder
  • World

Inherited Metabolic Disorders (Genetic Disorders) - Drugs in Development, 2021 Summary Inherited Metabolic Disorders (Genetic Disorders) - Drugs in Development, 2021 provides an overview of the Inherited Metabolic Disorders pipeline landscape. The report provides comprehensive information...

  • Endocrine Disease
  • Genetic Disorder
  • World

Tay-Sachs Disease (Genetic Disorders) - Drugs in Development, 2021 Summary Tay-Sachs Disease (Genetic Disorders) - Drugs in Development, 2021 provides an overview of the Tay-Sachs Disease pipeline landscape. The report provides comprehensive information on the therapeutics under development...

  • Genetic Disorder
  • Neurological Disorder
  • World

Charcot-Marie-Tooth Disease (Genetic Disorders) - Drugs in Development, 2021 Summary Charcot-Marie-Tooth Disease (Genetic Disorders) - Drugs in Development, 2021 provides an overview of the Charcot-Marie-Tooth Disease pipeline landscape. The report provides comprehensive information on the...

  • Genetic Disorder
  • World

Gaucher Disease Type II (Genetic Disorders) - Drugs in Development, 2021 Summary Gaucher Disease Type II (Genetic Disorders) - Drugs in Development, 2021 provides an overview of the Gaucher Disease Type II pipeline landscape. The report provides comprehensive information on the therapeutics...

  • Genetic Disorder
  • World

Maple Syrup Urine Disease (Genetic Disorders) - Drugs in Development, 2021 Summary Maple Syrup Urine Disease (Genetic Disorders) - Drugs in Development, 2021 provides an overview of the Maple Syrup Urine Disease pipeline landscape. The report provides comprehensive information on the therapeutics...

  • Genetic Disorder
  • World

Aicardi-Goutieres Syndrome (AGS) (Genetic Disorders) - Drugs in Development, 2021 Summary Aicardi-Goutieres Syndrome (AGS) (Genetic Disorders) - Drugs in Development, 2021 provides an overview of the Aicardi-Goutieres Syndrome (AGS) pipeline landscape. The report provides comprehensive information...

  • Genetic Disorder
  • World